"Cryptococcus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mitosporic Tremellales fungal genus whose species usually have a capsule and do not form pseudomycellium. Teleomorphs include Filobasidiella and Fidobasidium.
| Descriptor ID |
D003454
|
| MeSH Number(s) |
B01.300.381.258 B01.300.930.316
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cryptococcus".
Below are MeSH descriptors whose meaning is more specific than "Cryptococcus".
This graph shows the total number of publications written about "Cryptococcus" by people in this website by year, and whether "Cryptococcus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cryptococcus" by people in Profiles.
-
Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study. Clin Microbiol Infect. 2023 Aug; 29(8):1063-1069.
-
Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease. Clin Infect Dis. 2023 02 18; 76(4):649-657.
-
Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program. Clin Infect Dis. 2020 04 10; 70(8):1683-1690.
-
Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/µl identifies districts in South Africa with advanced burden of disease. PLoS One. 2018; 13(6):e0198993.
-
Estimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals. PLoS One. 2017; 12(8):e0182154.
-
Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/µl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa. PLoS One. 2017; 12(2):e0171675.
-
Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa. PLoS One. 2016; 11(7):e0158986.
-
Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J. 2012 Oct 08; 102(12):914-7.